Bioregenx Ratios (2021-2025) | BRGX

Ratios Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter) 71.02%67.78%71.89%55.76%69.90%64.01%80.81%70.09%78.82%79.03%83.98%82.66%
EBT Margin (Quarter) -484.41%-233.29%-19.42%-62.09%-21.37%-0.47%-0.46%-106.19%-128.25%-150.69%-66.25%-3,995.88%-51.80%-39.99%-15.87%-263.93%
EBIT Margin (Quarter) -484.41%-233.29%-19.42%-62.09%-17.12%-61.69%-310.69%-31.20%-560.36%-141.66%-54.91%-3,977.69%-37.39%-24.05%-1.67%-242.62%
EBITDA Margin (Quarter) -224.81%-790.17%161.38%-62.09%-20.92%-65.65%-317.04%-38.01%-573.46%-150.62%-66.68%-3,995.01%-52.20%-41.60%-14.44%-263.93%
Operating Margin (Quarter) -484.41%-233.29%-19.42%-62.09%-17.12%-61.69%-310.69%-31.20%-560.36%-141.66%-54.91%-3,977.69%-37.39%-24.05%-1.67%-242.62%
Net Margin (Quarter) -484.41%-233.29%-19.42%-62.09%-21.37%-0.47%-0.46%-106.19%-128.25%-150.69%-66.25%-3,995.88%-51.80%-39.99%-15.87%-263.93%
FCF Margin (Quarter) -271.55%-232.22%-55.46%-48.96%-31.31%-73.54%-35.68%-36.23%-53.43%-24.16%-5.23%-2.47%7.32%0.72%-15.28%17.26%
Efficiency
Inventory Average (Quarter) 0.22M0.18M0.15M0.13M0.13M0.14M0.12M0.11M
Assets Average (Quarter) 0.07M0.08M0.06M0.45M9.74M18.26M17.63M8.93M0.50M0.82M1.16M0.79M
Equity Average (Quarter) -0.09M-0.16M-0.21M-1.36M-2.47M-2.50M-2.69M-2.43M6.51M14.65M13.89M5.09M-3.47M-3.61M-3.65M-4.09M
Invested Capital (Quarter) 0.12M-0.10M-0.21M-0.20M-2.33M-2.22M-2.38M-2.60M-1.55M16.05M15.07M14.44M-2.24M-2.42M-2.68M-2.60M-3.53M
Asset Utilization Ratio (Quarter) 16.1924.2046.237.630.300.150.150.264.652.471.662.35
Leverage & Solvency
Interest Coverage Ratio (Quarter) -4.03-10.93-48.90-4.68-42.17-15.68-4.85-218.69-2.59-1.51-0.12-11.39
Debt to Equity (Quarter) -2.37-0.08-0.08-0.08-0.07-0.440.070.140.09-0.34-0.57-0.58-0.62-0.26
Debt Ratio (Quarter) 1.573.382.562.345.891.040.050.110.072.244.181.841.942.88
Equity Ratio (Quarter) -0.66-42.74-30.97-30.18-82.34-2.390.810.790.78-6.65-7.37-3.18-3.12-11.04
Times Interest Earned (Quarter) -4.03-10.93-48.90-4.68-42.17-15.68-4.85-218.69-2.59-1.51-0.12-11.39
Valuation
Enterprise Value (Quarter) -0.02M-0.00M-0.00M-0.00M-676.00-758.00-0.13M-0.11M-0.06M-0.07M-0.06M-0.08M-0.05M-0.05M-0.07M
Return Ratios
Return on Sales (Quarter) -0.05%-0.02%0.00%-0.01%0.00%0.00%0.00%-0.01%-0.01%-0.02%-0.01%-0.40%-0.01%0.00%0.00%-0.03%
Return on Capital Employed (Quarter) -764.15%-1,841.56%1,771.56%145.84%-99.15%-45.83%-33.02%-429.35%604.38%609.34%671.26%37.96%
Return on Assets (Quarter) -0.04%-0.03%-0.04%-0.02%0.00%0.00%0.00%-0.02%-0.41%-0.24%-0.16%-0.02%
Return on Equity (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.04%0.06%0.05%0.05%0.00%